Pulmuone Corporate (KRX:017810)
South Korea · Delayed Price · Currency is KRW 12,030
+130 (1.09%)
Last updated: Apr 8, 2026, 1:55 PM KST
Pulmuone Corporate Revenue
In the year 2025, Pulmuone Corporate had annual revenue of 3.38T KRW with 5.18% growth. Pulmuone Corporate had revenue of 859.19B in the quarter ending December 31, 2025, with 5.07% growth.
Revenue
3.38T
Revenue Growth
+5.18%
P/S Ratio
0.13
Revenue / Employee
6.65B
Employees
508
Market Cap
439.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.38T | 166.49B | 5.18% |
| Dec 31, 2024 | 3.21T | 220.23B | 7.36% |
| Dec 31, 2023 | 2.99T | 155.16B | 5.47% |
| Dec 31, 2022 | 2.84T | 319.41B | 12.68% |
| Dec 31, 2021 | 2.52T | 207.70B | 8.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daesang Holdings | 5.63T |
| Daesang | 4.40T |
| Sajodaerim | 3.50T |
| EASY HOLDINGS | 3.39T |
| SPC Samlip | 3.37T |
| Samyang | 2.56T |
| Kwang Dong Pharmaceutical | 1.66T |
| Binggrae | 1.49T |